{ "labelLang" : "hun", "responseDate" : "2024-03-29 16:48", "content" : { "otype" : "JournalArticle", "mtid" : 22942750, "status" : "APPROVED", "published" : true, "comment" : "Cited By :54 \n Export Date: 5 September 2019 \n CODEN: CPDEF \n Correspondence Address: Ge, R.; Department of Biological Sciences, National University of Singapore, Singapore 117543, Singapore; email: dbsgerw@nus.edu.sg \n Chemicals/CAS: amino acid, 65072-01-7; arginine, 1119-34-2, 15595-35-4, 7004-12-8, 74-79-3; arginylglycylaspartic acid, 99896-85-2; cilengitide, 188968-51-6; dehydrodidemnin B, 137219-37-5; endostatin, 187888-07-9; laminin, 2408-79-9; leucine, 61-90-5, 7005-03-0; n acetylsarcosylglycylvalyl dextro alloisoleucylthreonylnorvalylisoleucylarginylproline ethylamide, 251579-55-2, 251579-56-3; parathyroid hormone, 12584-96-2, 68893-82-3, 9002-64-6; pigment epithelium derived factor, 197980-93-1; proteinase, 9001-92-7; urokinase, 139639-24-0; vasculotropin, 127464-60-2; vasculotropin receptor, 301253-48-5; Angiogenesis Inhibitors; Autoantigens; Collagen Type IV; DNA, Recombinant; Endostatins; Extracellular Matrix Proteins; Eye Proteins; Laminin; Nerve Growth Factors; Peptide Library; Peptides; Proteoglycans; Receptor, TIE-2, 2.7.1.112; Serpins; Vascular Endothelial Growth Factor A; decorin; pigment epithelium-derived factor; type IV collagen alpha3 chain \n Tradenames: abt 510; abt 526; emd 121974; fk 228; fr 901228; im 862; pck 3145\nCited By :56 \n Export Date: 7 March 2020 \n CODEN: CPDEF \n Correspondence Address: Ge, R.; Department of Biological Sciences, National University of Singapore, Singapore 117543, Singapore; email: dbsgerw@nus.edu.sg \n Chemicals/CAS: amino acid, 65072-01-7; arginine, 1119-34-2, 15595-35-4, 7004-12-8, 74-79-3; arginylglycylaspartic acid, 99896-85-2; cilengitide, 188968-51-6; dehydrodidemnin B, 137219-37-5; endostatin, 187888-07-9; laminin, 2408-79-9; leucine, 61-90-5, 7005-03-0; n acetylsarcosylglycylvalyl dextro alloisoleucylthreonylnorvalylisoleucylarginylproline ethylamide, 251579-55-2, 251579-56-3; parathyroid hormone, 12584-96-2, 68893-82-3, 9002-64-6; pigment epithelium derived factor, 197980-93-1; proteinase, 9001-92-7; urokinase, 139639-24-0; vasculotropin, 127464-60-2; vasculotropin receptor, 301253-48-5; Angiogenesis Inhibitors; Autoantigens; Collagen Type IV; DNA, Recombinant; Endostatins; Extracellular Matrix Proteins; Eye Proteins; Laminin; Nerve Growth Factors; Peptide Library; Peptides; Proteoglycans; Receptor, TIE-2, 2.7.1.112; Serpins; Vascular Endothelial Growth Factor A; decorin; pigment epithelium-derived factor; type IV collagen alpha3 chain \n Tradenames: abt 510; abt 526; emd 121974; fk 228; fr 901228; im 862; pck 3145\nCited By :58 \n Export Date: 19 September 2020 \n CODEN: CPDEF \n Correspondence Address: Ge, R.; Department of Biological Sciences, National University of Singapore, Singapore 117543, Singapore; email: dbsgerw@nus.edu.sg \n Chemicals/CAS: amino acid, 65072-01-7; arginine, 1119-34-2, 15595-35-4, 7004-12-8, 74-79-3; arginylglycylaspartic acid, 99896-85-2; cilengitide, 188968-51-6; dehydrodidemnin B, 137219-37-5; endostatin, 187888-07-9; laminin, 2408-79-9; leucine, 61-90-5, 7005-03-0; n acetylsarcosylglycylvalyl dextro alloisoleucylthreonylnorvalylisoleucylarginylproline ethylamide, 251579-55-2, 251579-56-3; parathyroid hormone, 12584-96-2, 68893-82-3, 9002-64-6; pigment epithelium derived factor, 197980-93-1; proteinase, 9001-92-7; urokinase, 139639-24-0; vasculotropin, 127464-60-2; vasculotropin receptor, 301253-48-5; Angiogenesis Inhibitors; Autoantigens; Collagen Type IV; DNA, Recombinant; Endostatins; Extracellular Matrix Proteins; Eye Proteins; Laminin; Nerve Growth Factors; Peptide Library; Peptides; Proteoglycans; Receptor, TIE-2, 2.7.1.112; Serpins; Vascular Endothelial Growth Factor A; decorin; pigment epithelium-derived factor; type IV collagen alpha3 chain \n Tradenames: abt 510; abt 526; emd 121974; fk 228; fr 901228; im 862; pck 3145\nCited By :62 \n Export Date: 14 March 2021 \n CODEN: CPDEF \n Correspondence Address: Ge, R.; Department of Biological Sciences, , Singapore 117543, Singapore; email: dbsgerw@nus.edu.sg \n Chemicals/CAS: amino acid, 65072-01-7; arginine, 1119-34-2, 15595-35-4, 7004-12-8, 74-79-3; arginylglycylaspartic acid, 99896-85-2; cilengitide, 188968-51-6; dehydrodidemnin B, 137219-37-5; endostatin, 187888-07-9; laminin, 2408-79-9; leucine, 61-90-5, 7005-03-0; n acetylsarcosylglycylvalyl dextro alloisoleucylthreonylnorvalylisoleucylarginylproline ethylamide, 251579-55-2, 251579-56-3; parathyroid hormone, 12584-96-2, 68893-82-3, 9002-64-6; pigment epithelium derived factor, 197980-93-1; proteinase, 9001-92-7; urokinase, 139639-24-0; vasculotropin, 127464-60-2; vasculotropin receptor, 301253-48-5; Angiogenesis Inhibitors; Autoantigens; Collagen Type IV; DNA, Recombinant; Endostatins; Extracellular Matrix Proteins; Eye Proteins; Laminin; Nerve Growth Factors; Peptide Library; Peptides; Proteoglycans; Receptor, TIE-2, 2.7.1.112; Serpins; Vascular Endothelial Growth Factor A; decorin; pigment epithelium-derived factor; type IV collagen alpha3 chain \n Tradenames: abt 510; abt 526; emd 121974; fk 228; fr 901228; im 862; pck 3145", "unhandledTickets" : 0, "oldTimestamp" : "2018-10-01T21:43:43.000+0000", "deleted" : false, "oldId" : 12942750, "lastRefresh" : "2023-10-23T07:28:58.104+0000", "lastModified" : "2022-12-15T15:45:45.814+0000", "created" : "2013-02-10T22:00:19.000+0000", "creator" : { "otype" : "Author", "mtid" : 10010162, "link" : "/api/author/10010162", "label" : "Nagy Katalin (szájsebészet)", "familyName" : "Nagy", "givenName" : "Katalin", "duplumRole" : "DUPLUM", "published" : true, "oldId" : 10010162, "snippet" : true }, "lastDuplumSearch" : "2023-10-23T07:27:40.259+0000", "adminApproved" : "2013-02-10T22:06:05.000+0000", "adminApprover" : { "otype" : "Admin", "mtid" : 10018695, "link" : "/api/admin/10018695", "label" : "Bernátskyné Babus Csilla (SZTE admin4)", "familyName" : "Bernátskyné Babus", "givenName" : "Csilla", "published" : true, "oldId" : 10018695, "snippet" : true }, "core" : false, "citation" : true, "publicationPending" : false, "type" : { "otype" : "PublicationType", "mtid" : 24, "link" : "/api/publicationtype/24", "label" : "Folyóiratcikk", "code" : 24, "otypeName" : "JournalArticle", "listPosition" : 1, "published" : true, "oldId" : 24, "snippet" : true }, "subType" : { "otype" : "SubType", "mtid" : 10000059, "link" : "/api/subtype/10000059", "label" : "Szakcikk (Folyóiratcikk)", "name" : "Szakcikk", "nameEng" : "Article", "docType" : { "otype" : "PublicationType", "mtid" : 24, "link" : "/api/publicationtype/24", "label" : "Folyóiratcikk", "code" : 24, "otypeName" : "JournalArticle", "listPosition" : 1, "published" : true, "oldId" : 24, "snippet" : true }, "listPosition" : 101, "published" : true, "oldId" : 10000059, "snippet" : true }, "category" : { "otype" : "Category", "mtid" : 1, "link" : "/api/category/1", "label" : "Tudományos", "published" : true, "oldId" : 1, "snippet" : true }, "languages" : [ { "otype" : "Language", "mtid" : 10002, "link" : "/api/language/10002", "label" : "Angol", "name" : "Angol", "nameEng" : "English", "published" : true, "oldId" : 2, "snippet" : true } ], "firstAuthor" : "Sulochana, KN", "authorships" : [ { "otype" : "PersonAuthorship", "mtid" : 22716342, "link" : "/api/authorship/22716342", "label" : "Sulochana, KN", "listPosition" : 1, "share" : 0.0, "first" : true, "last" : false, "familyName" : "Sulochana", "givenName" : "KN", "authorTyped" : true, "editorTyped" : false, "otherTyped" : false, "type" : { "otype" : "AuthorshipType", "mtid" : 1, "link" : "/api/authorshiptype/1", "label" : "Szerző", "code" : 0, "published" : true, "oldId" : 0, "snippet" : true }, "published" : false, "oldId" : 33191914, "snippet" : true }, { "otype" : "PersonAuthorship", "mtid" : 22716343, "link" : "/api/authorship/22716343", "label" : "Ge, R", "listPosition" : 2, "share" : 0.0, "first" : false, "last" : true, "familyName" : "Ge", "givenName" : "R", "authorTyped" : true, "editorTyped" : false, "otherTyped" : false, "type" : { "otype" : "AuthorshipType", "mtid" : 1, "link" : "/api/authorshiptype/1", "label" : "Szerző", "code" : 0, "published" : true, "oldId" : 0, "snippet" : true }, "published" : false, "oldId" : 33191913, "snippet" : true } ], "title" : "Developing antiangiogenic peptide drugs for angiogenesis-related diseases", "identifiers" : [ { "otype" : "PublicationIdentifier", "mtid" : 5900306, "link" : "/api/publicationidentifier/5900306", "label" : "DOI: 10.2174/138161207781039715", "source" : { "otype" : "PlainSource", "mtid" : 6, "link" : "/api/publicationsource/6", "label" : "DOI", "type" : { "otype" : "PublicationSourceType", "mtid" : 10001, "link" : "/api/publicationsourcetype/10001", "label" : "DOI", "mayHaveOa" : true, "published" : true, "snippet" : true }, "name" : "DOI", "nameEng" : "DOI", "linkPattern" : "https://doi.org/@@@", "publiclyVisible" : true, "published" : true, "oldId" : 6, "snippet" : true }, "validState" : "IDENTICAL", "idValue" : "10.2174/138161207781039715", "realUrl" : "https://doi.org/10.2174/138161207781039715", "published" : false, "oldId" : 3006357, "snippet" : true }, { "otype" : "PublicationIdentifier", "mtid" : 5900304, "link" : "/api/publicationidentifier/5900304", "label" : "WoS: 000247898600005", "source" : { "otype" : "PlainSource", "mtid" : 1, "link" : "/api/publicationsource/1", "label" : "WoS", "type" : { "otype" : "PublicationSourceType", "mtid" : 10003, "link" : "/api/publicationsourcetype/10003", "label" : "Indexelő adatbázis", "mayHaveOa" : false, "published" : true, "snippet" : true }, "name" : "WoS", "nameEng" : "WoS", "linkPattern" : "https://www.webofscience.com/wos/woscc/full-record/@@@", "publiclyVisible" : true, "published" : true, "oldId" : 1, "snippet" : true }, "validState" : "IDENTICAL", "idValue" : "000247898600005", "realUrl" : "https://www.webofscience.com/wos/woscc/full-record/000247898600005", "published" : false, "oldId" : 7371753, "snippet" : true }, { "otype" : "PublicationIdentifier", "mtid" : 5900305, "link" : "/api/publicationidentifier/5900305", "label" : "Scopus: 34447291351", "source" : { "otype" : "PlainSource", "mtid" : 3, "link" : "/api/publicationsource/3", "label" : "Scopus", "type" : { "otype" : "PublicationSourceType", "mtid" : 10003, "link" : "/api/publicationsourcetype/10003", "label" : "Indexelő adatbázis", "mayHaveOa" : false, "published" : true, "snippet" : true }, "name" : "Scopus", "linkPattern" : "http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-@@@", "publiclyVisible" : true, "published" : true, "oldId" : 3, "snippet" : true }, "validState" : "IDENTICAL", "idValue" : "34447291351", "realUrl" : "http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-34447291351", "published" : false, "oldId" : 3006358, "snippet" : true }, { "otype" : "PublicationIdentifier", "mtid" : 5900307, "link" : "/api/publicationidentifier/5900307", "label" : "PubMed: 17627540", "source" : { "otype" : "PlainSource", "mtid" : 17, "link" : "/api/publicationsource/17", "label" : "PubMed", "type" : { "otype" : "PublicationSourceType", "mtid" : 10003, "link" : "/api/publicationsourcetype/10003", "label" : "Indexelő adatbázis", "mayHaveOa" : false, "published" : true, "snippet" : true }, "name" : "PubMed", "nameEng" : "PubMed", "linkPattern" : "http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=@@@&dopt=Abstract", "publiclyVisible" : true, "published" : true, "oldId" : 17, "snippet" : true }, "validState" : "IDENTICAL", "idValue" : "17627540", "realUrl" : "http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17627540&dopt=Abstract", "published" : false, "oldId" : 3385409, "snippet" : true } ], "journal" : { "otype" : "Journal", "mtid" : 2017110, "link" : "/api/journal/2017110", "label" : "CURRENT PHARMACEUTICAL DESIGN 1381-6128 1873-4286", "pIssn" : "1381-6128", "eIssn" : "1873-4286", "reviewType" : "REVIEWED", "noIF" : false, "sciIndexed" : true, "scopusIndexed" : true, "lang" : "FOREIGN", "hungarian" : false, "published" : true, "oldId" : 2017110, "snippet" : true }, "volume" : "13", "issue" : "20", "firstPage" : "2074", "lastPage" : "2086", "firstPageOrInternalIdForSort" : "2074", "pageLength" : 13, "publishedYear" : 2007, "digital" : null, "printed" : null, "sourceYear" : 2013, "packet" : "601423", "foreignEdition" : true, "foreignLanguage" : true, "fullPublication" : true, "conferencePublication" : false, "nationalOrigin" : null, "missingAuthor" : false, "oaType" : "NONE", "oaCheckDate" : "2023-10-23", "oaFree" : false, "citationCount" : 0, "citationCountUnpublished" : 0, "citationCountWoOther" : 0, "independentCitCountWoOther" : 0, "doiCitationCount" : 0, "wosCitationCount" : 0, "scopusCitationCount" : 0, "independentCitationCount" : 0, "unhandledCitationCount" : 0, "citingPubCount" : 0, "independentCitingPubCount" : 0, "unhandledCitingPubCount" : 0, "citedPubCount" : 2, "citedCount" : 2, "ratings" : [ { "otype" : "SjrRating", "mtid" : 5899619, "link" : "/api/sjrrating/5899619", "label" : "sjr:D1 (2007) Scopus - Drug Discovery CURRENT PHARMACEUTICAL DESIGN 1381-6128 1873-4286", "listPos" : 12, "rankValue" : 0.1, "type" : "journal", "ratingType" : { "otype" : "RatingType", "mtid" : 10002, "link" : "/api/ratingtype/10002", "label" : "sjr", "code" : "sjr", "published" : true, "snippet" : true }, "subject" : { "otype" : "ClassificationExternal", "mtid" : 3002, "link" : "/api/classificationexternal/3002", "label" : "Scopus - Drug Discovery", "published" : true, "oldId" : 3002, "snippet" : true }, "ranking" : "D1", "calculation" : "DIRECT", "published" : true, "oldId" : 5899619, "snippet" : true } ], "ratingsForSort" : "D1", "references" : [ { "otype" : "Reference", "mtid" : 16790419, "link" : "/api/reference/16790419", "label" : "1. Carmeliet, P., Angiogenesis in life, disease and medicine (2005) Nature, 438, pp. 932-936", "listPosition" : 1, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790420, "link" : "/api/reference/16790420", "label" : "2. Ferrara, N., Kerbel, R.S., Angiogenesis as a therapeutic target (2005) Nature, 438, pp. 967-974", "listPosition" : 2, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790421, "link" : "/api/reference/16790421", "label" : "3. Lien, S., Lowman, H.B., Therapeutic peptides (2003) Trends Biotechnol, 21, pp. 556-562", "listPosition" : 3, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790422, "link" : "/api/reference/16790422", "label" : "4. Ruoslahti, E., Duza, T., Zhang, L., Vascular homing peptides with cell-penetrating properties (2005) Curr Pharm Des, 11, pp. 3655-3660", "listPosition" : 4, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790423, "link" : "/api/reference/16790423", "label" : "5. Ruegg, C., Hasmim, M., Lejeune, F.J., Alghisi, G.C., Antiangiogenic peptides and proteins: From experimental tools to clinical drugs (2006) Biochim Biophys Acta, 1765, pp. 155-177", "listPosition" : 5, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790424, "link" : "/api/reference/16790424", "label" : "6. IruelaArispe, M.L., Luque, A., Lee, N., Thrombospondin modules and angiogenesis (2004) Int J Biochem Cell Biol, 36, pp. 1070-1087", "listPosition" : 6, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790425, "link" : "/api/reference/16790425", "label" : "7. Thrombospondins, F.W.A., (1991) Curr Opin Cell Biol, 3, pp. 792-799", "listPosition" : 7, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790426, "link" : "/api/reference/16790426", "label" : "8. Chen, H., Herndon, M.E., Lawler, J., The cell biology of thrombospondin-1 (2000) Matrix Biol, 19, pp. 597-614", "listPosition" : 8, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790427, "link" : "/api/reference/16790427", "label" : "9. Tolsma, S.S., Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity (1993) J Cell Biol, 122, pp. 497-511", "listPosition" : 9, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790428, "link" : "/api/reference/16790428", "label" : "10. Dawson, D.W., Three distinct D-amino acid substitutions confer potent antiangiogenic activity on an inactive peptide derived from a thrombospondin-1 type 1 repeat (1999) Mol Pharmacol, 55, pp. 332-338", "listPosition" : 10, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790429, "link" : "/api/reference/16790429", "label" : "11. Reiher, F.K., Inhibition of tumor growth by systemic treatment with thrombospondin-1 peptide mimetics (2002) Int J Cancer, 98, pp. 682-689", "listPosition" : 11, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790430, "link" : "/api/reference/16790430", "label" : "12. Haviv, F., Bradley, M.F., Kalvin, D.M., Schneider, A.J., Davidson, D.J., Majest, S.M., Thrombospondin-1 mimetic peptide inhibitors of angiogenesis and tumor growth: Design, synthesis, and optimization of pharmacokinetics and biological activities (2005) J Med Chem, 48, pp. 2838-2846", "listPosition" : 12, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790431, "link" : "/api/reference/16790431", "label" : "13. Iruela-Arispe, M.L., Lombardo, M., Krutzsch, H.C., Lawler, J., Roberts, D.D., Inhibition of angiogenesis by thrombospondin-1 is mediated by 2 independent regions within the type 1 repeats (1999) Circulation, 100, pp. 1423-1423", "listPosition" : 13, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790432, "link" : "/api/reference/16790432", "label" : "14. Guo, N., Krutzsch, H.C., Inman, J.K., Roberts, D.D., Thrombospondin 1 and type I repeat peptides of thrombospondin 1 specifically induce apoptosis of endothelial cells (1997) Cancer Res, 57, pp. 1735-1742", "listPosition" : 14, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790433, "link" : "/api/reference/16790433", "label" : "15. Shafiee, A., Penn, J.S., Krutzsch, H.C., Inman, J.K., Roberts, D.D., Blake, D.A., Inhibition of retinal angiogenesis by peptides derived from thrombospondin-1 (2000) Invest Ophthalmol Vis Sci, 41, pp. 2378-2388", "listPosition" : 15, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790434, "link" : "/api/reference/16790434", "label" : "16. O'Reilly, M.S., Boehm, T., Shing, Y., Fukai, N., Vasios, G., Lane, W.S., Endostatin: An endogenous inhibitor of angiogenesis and tumor growth (1997) Cell, 88, pp. 277-285", "listPosition" : 16, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790435, "link" : "/api/reference/16790435", "label" : "17. Dhanabal, M., Volk, R., Ramchandran, R., Simons, M., Sukhatme, V.P., Cloning, expression, and in vitro activity of human endostatin (1999) Biochem Biophys Res Commun, 258, pp. 345-352", "listPosition" : 17, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790436, "link" : "/api/reference/16790436", "label" : "18. Herbst, R.S., Hess, K.R., Tran, H.T., Tseng, J.E., Mullani, N.A., Chamsangavej, C., Phase I study of recombinant human endostatin in patients with advanced solid tumors (2002) J Clin Oncol, 20, pp. 3792-3803", "listPosition" : 18, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790437, "link" : "/api/reference/16790437", "label" : "19. Hansma, A.H., Broxterman, H.J., van der Horst, I., Yuana, Y., Boven, E., Giaccone, G., Recombinant human endostatin administered as a 28-day continuous intravenous infusion, followed by daily subcutaneous injections: A phase I and pharmacokinetic study in patients with advanced cancer (2005) Ann Oncol, 16, pp. 1695-1701", "listPosition" : 19, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790438, "link" : "/api/reference/16790438", "label" : "20. Karumanchi, S.A., Jha, V., Ramchandran, R., Karihaloo, A., Tsiokas, L., Chan, B., Cell surface glypicans are low-affinity endostatin receptors (2001) Mol Cell, 7, pp. 811-822", "listPosition" : 20, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790439, "link" : "/api/reference/16790439", "label" : "21. Rehn, M., Veikkola, T., Kukk-Valdre, E., Nakamura, H., Ilmonen, M., Lombardo, C., Interaction of endostatin with integrins implicated in angiogenesis (2001) Proc Natl Acad Sci USA, 98, pp. 1024-1029", "listPosition" : 21, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790440, "link" : "/api/reference/16790440", "label" : "22. Ding, Y.H., Javaherian, K., Lo, K.M., Chopra, R., Boehm, T., Lanciotti, J., Zinc-dependent dimers observed in crystals of human endostatin (1998) Proc Natl Acad Sci USA, 95, pp. 10443-10448", "listPosition" : 22, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790441, "link" : "/api/reference/16790441", "label" : "23. Yokoyama, Y., Ramakrishnan, S., Addition of integrin binding sequence to a mutant human endostatin improves inhibition of tumor growth (2004) Int J Cancer, 111, pp. 839-848", "listPosition" : 23, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790442, "link" : "/api/reference/16790442", "label" : "24. Cattaneo, M.G., Pola, S., Francescato, P., Chillemi, F., Vicentini, L.M., Human endostatin-derived synthetic peptides possess potent antiangiogenic properties in vitro and in vivo (2003) Exp Cell Res, 283, pp. 230-236", "listPosition" : 24, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790443, "link" : "/api/reference/16790443", "label" : "25. Olsson, A.K., Johansson, I., Akerud, H., Einarsson, B., Christofferson, R., Sasaki, T., The minimal active domain of endostatin is a heparin-binding motif that mediates inhibition of tumor vascularization (2004) Cancer Res, 64, pp. 9012-9017", "listPosition" : 25, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790444, "link" : "/api/reference/16790444", "label" : "26. Wickstrom, S.A., Alitalo, K., Keski-Oja, J., An endostatin-derived peptide interacts with integrins and regulates actin cytoskeleton and migration of endothelial cells (2004) J Biol Chem, 279, pp. 20178-20185", "listPosition" : 26, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790445, "link" : "/api/reference/16790445", "label" : "27. Tjin Tham Sjin RM, Satchi-Fainaro R, Birsner AE, Ramanujam VM, Folkman J, Javaherian K. A 27-amino-acid synthetic peptide corresponding to the NH2 terminal zinc-binding domain of endostatin is responsible for its antitumor activity. Cancer Res 2005; 65: 3656-63Becker, C.M., Sampson, D.A., Short, S.M., Javaherian, K., Folkman, J., D'Amato, R.J., Short synthetic endostatin peptides inhibit endothelial migration in vitro and endometriosis in a mouse model (2006) Fertil Steril, 85, pp. 71-77", "listPosition" : 27, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790446, "link" : "/api/reference/16790446", "label" : "28. Becker, C.M., Sampson, D.A., Rupnick, M.A., Rohan, R.M., Efstathiou, J.A., Short, S.M., Endostatin inhibits the growth of endometriotic lesions but does not affect fertility (2005) Fertil Steril, 84 (SUPPL. 2), pp. 1144-1155", "listPosition" : 28, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790447, "link" : "/api/reference/16790447", "label" : "29. Iozzo, R.V., The family of the small leucine-rich proteoglycans: Key regulators of matrix assembly and cellular growth (1997) Crit Rev Biochem Mol Biol, 32, pp. 141-174", "listPosition" : 29, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790448, "link" : "/api/reference/16790448", "label" : "30. Schmidt, G., Robenek, H., Harrach, B., Glossl, J., Nolte, V., Hormann, H., Interaction of small dermatan sulfate proteoglycan from fibroblasts with fibronectin (1987) J Cell Biol, 104, pp. 1683-1691", "listPosition" : 30, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790449, "link" : "/api/reference/16790449", "label" : "31. Winnemoller, M., Schon, P., Vischer, P., Kresse, H., Interactions between thrombospondin and the small proteoglycan decorin: Interference with cell attachment (2005) J Biol Chem, 280, pp. 27935-27948", "listPosition" : 31, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790450, "link" : "/api/reference/16790450", "label" : "32. Yamaguchi, Y., Mann, D.M., Ruoslahti, E., Negative regulation of transforming growth factor-beta by the proteoglycan decorin (1990) Nature, 346, pp. 281-284", "listPosition" : 32, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790451, "link" : "/api/reference/16790451", "label" : "33. Grant, D.S., Yenisey, C., Rose, R.W., Tootell, M., Santra, M., Iozzo, R.V., Decorin suppresses tumor cell-mediated angiogenesis (2002) Oncogene, 21, pp. 4765-4777", "listPosition" : 33, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790452, "link" : "/api/reference/16790452", "label" : "34. Matushima, N., Ohyanagi, T., Tanaka, T., Kretsinger, R.H., Super-motifs and evolution of tandem leucine-rich repeats within the small proteoglycans-biglycan, decorin, lumican, fibromodulin, PRELP, keratocan, osteoadherin, epiphycan, and osteoglycin (2000) Proteins, 38, pp. 210-225", "listPosition" : 34, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790453, "link" : "/api/reference/16790453", "label" : "35. Sulochana, K.N., Fan, H., Jois, S., Subramanian, V., Sun, F., Kini, R.M., Peptides derived from human decorin leucine-rich repeat 5 inhibit angiogenesis (2005) J Biol Chem, 280, pp. 27935-27948", "listPosition" : 35, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790454, "link" : "/api/reference/16790454", "label" : "36. Maeshima, Y., Sudhakar, A., Lively, J.C., Ueki, K., Kharbanda, S., Kahn, C.R., Tumstatin, an endothelial cell-specific inhibitor of protein synthesis (2002) Science, 295, pp. 140-143", "listPosition" : 36, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790455, "link" : "/api/reference/16790455", "label" : "37. Maeshima, Y., Yerramalla, U.L., Dhanabal, M., Holthaus, K.A., Barbashov, S., Kharbanda, S., Extracellular matrix-derived peptide binds to alpha(v)beta(3) integrin and inhibits angiogenesis (2001) J Biol Chem, 276, pp. 31959-31968", "listPosition" : 37, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790456, "link" : "/api/reference/16790456", "label" : "38. Juarez, J.C., Guan, X., Shipulina, N.V., Plunkett, M.L., Parry, G.C., Shaw, D.E., Histidine-proline-rich glycoprotein has potent antiangiogenic activity mediated through the histidine-proline-rich domain (2002) Cancer Res, 62, pp. 5344-5350", "listPosition" : 38, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790457, "link" : "/api/reference/16790457", "label" : "39. Guan, X., Juarez, J.C., Qi, X., Shipulina, N.V., Shaw, D.E., Morgan, W.T., Histidine-proline rich glycoprotein (HPRG) binds and transduces anti-angiogenic signals through cell surface tropomyosin on endothelial cells (2004) Thromb Haemost, 92, pp. 403-412", "listPosition" : 39, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790458, "link" : "/api/reference/16790458", "label" : "40. Donate, F., Juarez, J.C., Guan, X., Shipulina, N.V., Plunkett, M.L., Tel-Tsur, Z., Peptides derived from the histidine-proline domain of the histidine-proline-rich glycoprotein bind to tropomyosin and have antiangiogenic and antitumor activities (2004) Cancer Res, 64, pp. 5812-5817", "listPosition" : 40, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790459, "link" : "/api/reference/16790459", "label" : "41. Fazekas, K., Janovics, A., Dome, B., Koska, P., Albini, A., Timar, J., Effect of HGF-like basic hexapeptides on angiogenesis (2001) Microvasc Res, 62, pp. 440-444", "listPosition" : 41, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790460, "link" : "/api/reference/16790460", "label" : "42. Dixelius, J., Olsson, A.K., Thulin, A., Lee, C., Johansson, I., Claesson-Welsh, L., Minimal active domain and mechanism of action of the angiogenesis inhibitor histidine-rich glycoprotein (2006) Cancer Res, 66, pp. 2089-2097", "listPosition" : 42, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790461, "link" : "/api/reference/16790461", "label" : "43. Bakre, M.M., Zhu, Y., Yin, H., Burton, D.W., Terkeltaub, R., Deftos, L.J., Parathyroid hormone- related peptide is a naturally occurring, protein kinase A-dependent angiogenesis inhibitor (2002) Nat Med, 8, pp. 995-1003", "listPosition" : 43, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790462, "link" : "/api/reference/16790462", "label" : "44. Maione, T.E., Gray, G.S., Petro, J., Hunt, A.J., Donner, A.L., Bauer, S.I., Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides (1990) Science, 247, pp. 77-79", "listPosition" : 44, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790463, "link" : "/api/reference/16790463", "label" : "45. Jouan, V., Canron, X., Alemany, M., Caen, J.P., Quentin, G., Plouet, J., Inhibition of in vitro angiogenesis by platelet factor-4-derived peptides and mechanism of action (1999) Blood, 94, pp. 984-993", "listPosition" : 45, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790464, "link" : "/api/reference/16790464", "label" : "46. Guo, Y.L., Wang, S., Colman, R.W., Kininostatin as an antiangiogenic inhibitor: What we know and what we do not know (2002) Int Immunopharmacol, 2, pp. 1931-1940", "listPosition" : 46, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790465, "link" : "/api/reference/16790465", "label" : "47. Colman, R.W., Inhibition of angiogenesis by a monoclonal antibody to kininogen as well as by kininostatin which block proangiogenic high molecular weight kininogen (2002) Int Immunopharmacol, 2, pp. 1887-1894", "listPosition" : 47, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790466, "link" : "/api/reference/16790466", "label" : "48. Colman, R.W., Jameson, B.A., Lin, Y., Johnson, D., Mousa, S.A., Domain 5 of high molecular weight kininogen (Kininostatin) down-regulates endothelial cell proliferation and migration and inhibits angiogenesis (2000) Blood, 95, pp. 543-550", "listPosition" : 48, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790467, "link" : "/api/reference/16790467", "label" : "49. Bouck, N., PEDF: Anti-angiogenic guardian of ocular function (2002) Trends Mol Med, 8, pp. 330-334", "listPosition" : 49, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790468, "link" : "/api/reference/16790468", "label" : "50. Filleur, S., Volz, K., Nelius, T., Mirochnik, Y., Huang, H., Zaichuk, T.A., Two functional epitopes of pigment epithelial-derived factor block angiogenesis and induce differentiation in prostate cancer (2005) Cancer Res, 65, pp. 5144-5152", "listPosition" : 50, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790469, "link" : "/api/reference/16790469", "label" : "51. Kern, B.E., Balcom, J.H., Antoniu, B.A., Warshaw, A.L., Fernandez-del Castillo, C., Troponin I peptide (Glu94-Leu123), a cartilage-derived angiogenesis inhibitor: In vitro and in vivo effects on human endothelial cells and on pancreatic cancer (2003) J Gastrointest Surg, 7, pp. 961-968", "listPosition" : 51, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790470, "link" : "/api/reference/16790470", "label" : "52. Ferrara, N., VEGF as a therapeutic target in cancer (2005) Oncology, 69 (SUPPL. 3), pp. 11-16", "listPosition" : 52, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790471, "link" : "/api/reference/16790471", "label" : "53. Ferrara, N., Gerber, H.P., LeCouter, The biology of VEGF and its receptors (2003) J Nat Med, 9, pp. 669-676", "listPosition" : 53, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790472, "link" : "/api/reference/16790472", "label" : "54. Jia, H., Jezequel, S., Lohr, M., Shaikh, S., Davis, D., Soker, S., Peptides encoded by exon 6 of VEGF inhibit endothelial cell biological responses and angiogenesis induced by VEGF (2001) Biochem Biophys Res Commun, 283, pp. 164-173", "listPosition" : 54, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790473, "link" : "/api/reference/16790473", "label" : "55. Bainbridge, J.W., Jia, H., Bagherzadeh, A., Selwood, D., Ali, R.R., Zachary, I., A peptide encoded by exon 6 of VEGF (EG3306) inhibits VEGF-induced angiogenesis in vitro and ischaemic retinal neovascularization in vivo (2003) Biochem Biophys Res Commun, 302, pp. 793-799", "listPosition" : 55, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790474, "link" : "/api/reference/16790474", "label" : "56. Binetruy-Tournaire, R., Demangel, C., Malavaud, B., Vassy, R., Rouyre, S., Kraemer, M., Identification of a peptide blocking vascular endothelial growth factor (VEGF)-mediated angiogenesis (2000) EMBO J, 19, pp. 1525-1533", "listPosition" : 56, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790475, "link" : "/api/reference/16790475", "label" : "57. Tirand L, Frochot C, Vanderesse R, Thomas N, Trinquet E, Pinel S, et al. A peptide competing with VEGF(165) binding on neuropilin-1 mediates targeting of a chlorin-type photosensitizer and potentiates its photodynamic activity in human endothelial cells. J Control Release 2006; 111: 153-64Hetian, L., Ping, A., Shumei, S., Xiaoying, L., Luowen, H., Jian, W., A novel peptide isolated from a phage display library inhibits tumor growth and metastasis by blocking the binding of vascular endothelial growth flictor to its kinase domain receptor (2002) J Biol Chem, 277, pp. 43137-43142", "listPosition" : 57, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790476, "link" : "/api/reference/16790476", "label" : "58. Piossek, C., Schneider-Mergener, J., Schimer, M., Vakalopoulou, E., Germeroth, L., Thierauch, K.H., Vascular endothelial growth factor (VEGF) receptor II-derived peptides inhibit VEGF (1999) J Biol Chem, 274, pp. 5612-5959", "listPosition" : 58, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790477, "link" : "/api/reference/16790477", "label" : "59. El-Mousawi, M., Tchistiakova, L., Yurchenko, L., Pietrzynski, G., Moreno, M., Stanimirovic, D., A vascular endothelial growth factor high affinity receptor 1-specific peptide with antiangiogenic activity identified using a phage display peptide library (2003) J Biol Chem, 278, pp. 46681-46691", "listPosition" : 59, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790478, "link" : "/api/reference/16790478", "label" : "60. Bae, D.G., Kim, T.D., Li, G., Yoon, W.H., Chae, C.B., Anti-flt1 peptide, a vascular endothelial growth factor receptor 1-specific hexapeptide, inhibits tumor growth and metastasis (2005) Clin Cancer Res, 11, pp. 651-661", "listPosition" : 60, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790479, "link" : "/api/reference/16790479", "label" : "61. Toumaire, R., Simon, M.P., le Noble, F., Eichmann, A., England, P., Pouyssegur, J., A short syntheticpeptide inhibits signal transduction, migration and angiogenesis mediated by Tie2 receptor (2004) EMBO Rep, 5, pp. 262-267", "listPosition" : 61, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790480, "link" : "/api/reference/16790480", "label" : "62. Wu, X., Zhao, R., Li, Z., Yao, M., Wang, H., Han, J., A novel small peptide as a targeting ligand for receptor tyrosine kinase Tie2 (2004) Biochem Biophys Res Commun, 315, pp. 1004-1010", "listPosition" : 62, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790481, "link" : "/api/reference/16790481", "label" : "63. Nicosia, R.F., Bonanno, E., Smith, M., Fibronectin promotes the elongation of microvessels during angiogenesis in vitro (1993) J Cell Physiol, 154, pp. 654-661", "listPosition" : 63, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790482, "link" : "/api/reference/16790482", "label" : "64. Saiki, I., Murata, J., Matsuno, K., Ogawa, R., Nishi, N., Tokura, S., Anti-metastatic and anti-invasive effects of polymeric Arg-Gly-Asp (RGD) peptide, poly(RGD), and its analogues (1990) Jpn J Cancer Res, 81, pp. 660-667", "listPosition" : 64, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790483, "link" : "/api/reference/16790483", "label" : "65. Buerkle, M.A., Pahernik, S.A., Sutter, A., Jonczyk, A., Messmer, K., Dellian, M., Inhibition of the alpha-nu integrins with a cyclic RGD peptide impairs angiogenesis, growth and metastasis of solid tumours in vivo (2002) Br J Cancer, 86, pp. 788-795", "listPosition" : 65, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790484, "link" : "/api/reference/16790484", "label" : "66. Mousa, S.A., Alpha v integrin affinity/specificity and antiangiogenesis effect of a novel tetraaza cyclic peptide derivative, SU015, in various species (2005) J Cardiovasc Pharmacol, 45, pp. 462-467", "listPosition" : 66, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790485, "link" : "/api/reference/16790485", "label" : "67. Malinda, K.M., Nomizu, M., Chung, M., Delgado, M., Kuratomi, Y., Yamada, Y., Identification of laminin alphal and betal chain peptides active for endothelial cell adhesion, tube formation, and aortic sprouting (1999) FASEB J, 13, pp. 53-62", "listPosition" : 67, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790486, "link" : "/api/reference/16790486", "label" : "68. Ponce, M.L., Nomizu, M., Delgado, M.C., Kuratomi, Y., Hoffman, M.P., Powell, S., Identification of endothelial cell binding sites on the laminin gamma 1 chain (1999) Circ Res, 84, pp. 688-694", "listPosition" : 68, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790487, "link" : "/api/reference/16790487", "label" : "69. Ponce, M.L., Nomizu, M., Kleinman, H.K., An angiogenic laminin site and its antagonist bind through the alpha(v)beta3 and alpha5beta1 integrins (2001) FASEB J, 15, pp. 1389-1397", "listPosition" : 69, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790488, "link" : "/api/reference/16790488", "label" : "70. Ponce, M.L., Hibino, S., Lebioda, A.M., Mochizuki, M., Nomizu, M., Kleinman, H.K., Identification of a potent peptide antagonist to an active laminin-1 sequence that blocks angiogenesis and tumor growth (2003) Cancer Res, 63, pp. 5060-5064", "listPosition" : 70, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790489, "link" : "/api/reference/16790489", "label" : "71. Guo, Y., Higazi, A.A., Arakelian, A., Sachais, B.S., Cines, D., Goldfarb, R.H., A peptide derived from the nonreceptor binding region of urokinase plasminogen activator (uPA) inhibits tumor progression and angiogenesis and induces tumor cell death in vivo (2000) FASEB J, 14, pp. 1400-1410", "listPosition" : 71, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790490, "link" : "/api/reference/16790490", "label" : "72. Griffioen, A.W., van der Schaft, D.W., Barendsz-Janson, A.F., Cox, A., Struijker Boudier, H.A., Anginex, a designed peptide that inhibits angiogenesis (2001) Biochem J, 354, pp. 233-242", "listPosition" : 72, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790491, "link" : "/api/reference/16790491", "label" : "73. Mayo, K.H., van der Schaft, D.W., Griffioen, A.W., Designed beta-sheet peptides that inhibit proliferation and induce apoptosis in endothelial cells (2001) Angiogenesis, 4, pp. 45-51", "listPosition" : 73, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790492, "link" : "/api/reference/16790492", "label" : "74. Dings, R.P., Arroyo, M.M., Lockwood, N.A., van Eijk, L.I., Haseman, J.R., Griffioen, A.W., Beta-sheet is the bioactive conformation of the anti-angiogenic anginex peptide (2003) Biochem J, 373, pp. 281-288", "listPosition" : 74, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790493, "link" : "/api/reference/16790493", "label" : "75. Mayo, K.H., Dings, R.P., Flader, C., Nesmelova, I., Hargittai, B., van der Schaft, D.W., Design of a partial peptide mimetic of anginex with antiangiogenic and anticancer activity (2003) J Biol Chem, 278, pp. 45746-45752", "listPosition" : 75, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790494, "link" : "/api/reference/16790494", "label" : "76. Van der Schaft, D.W., Dings, R.P., de Lussanet, Q.G., van Eijk, L.I., Nap, A.W., Beets-Tan, R.G., The designer anti-angiogenic peptide anginex targets tumor endothelial cells and inhibits tumor growth in animal models (2002) FASEB J, 16, pp. 1991-1993", "listPosition" : 76, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790495, "link" : "/api/reference/16790495", "label" : "77. Dings, R.P., van der Schaft, D.W., Hargittai, B., Haseman, J., Griffioen, A.W., Mayo, K.H., Anti-tumor activity of the novel angiogenesis inhibitor anginex (2003) Cancer Lett, 194, pp. 55-66", "listPosition" : 77, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790496, "link" : "/api/reference/16790496", "label" : "78. Dings, R.P., Yokoyama, Y., Ramakrishnan, S., Griffioen, A.W., Mayo, K.H., The designed angiostatic peptide anginex synergistically improves chemotherapy and antiangiogenesis therapy with angiostatin (2003) Cancer Res, 63, pp. 382-385", "listPosition" : 78, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790497, "link" : "/api/reference/16790497", "label" : "79. Dings, R.P., Williams, B.W., Song, C.W., Griffioen, A.W., Mayo, K.H., Griffin, R.J., Anginex synergizes with radiation therapy to inhibit tumor growth by radiosensitizing endothelial cells (2005) Int J Cancer, 115, pp. 312-319", "listPosition" : 79, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790498, "link" : "/api/reference/16790498", "label" : "80. Pilch, J., Franzin, C.M., Knowles, L.M., Ferrer, F.J., Marassi, F.M., Ruoslahti, E., The anti-angiogenic peptide anginex disrupts the cell membrane (2006) J Mol Biol, 356, pp. 876-885", "listPosition" : 80, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790499, "link" : "/api/reference/16790499", "label" : "81. Akerman, M.E., Pilch, J., Peters, D., Ruoslahti, E., Angiostatic peptides use plasma fibronectin to home to angiogenic vasculature (2005) Proc Natl Acad Sci USA, 102, pp. 2040-2045", "listPosition" : 81, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790500, "link" : "/api/reference/16790500", "label" : "82. Ruoslahti, E., Vascular zip codes in angiogenesis and metastasis (2004) Biochem Soc Trans, 32, pp. 397-402", "listPosition" : 82, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790501, "link" : "/api/reference/16790501", "label" : "83. Pilch, J., Brown, D.M., Komatsu, M., Jarvinen, T.A., Yang, M., Peters, D., Peptides selected for binding to clotted plasma accumulate in tumor stroma and wounds (2006) Proc Natl Acad Sci USA, 103, pp. 2800-2804", "listPosition" : 83, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790502, "link" : "/api/reference/16790502", "label" : "84. Arap, W., Pasqualini, F., Ruoslahti, E., Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model (1998) Science, 279, pp. 377-380", "listPosition" : 84, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790503, "link" : "/api/reference/16790503", "label" : "85. Arap, W., Pasqualini, R., Ruoslahti, E., Chemotherapy targeted to tumor vasculature (1998) Curr Opin Oncol, 10, pp. 560-565", "listPosition" : 85, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790504, "link" : "/api/reference/16790504", "label" : "86. Van Laarhoven, H.W., Gambarota, G., Heerschap, A., Lok, J., Verhagen, I., Corti, A., Effects of the tumor vasculature targeting agent NGR-TNF on the tumor microenvironment in murine lymphomas (2006) Invest New Drugs, 24, pp. 27-36", "listPosition" : 86, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790505, "link" : "/api/reference/16790505", "label" : "87. Su, J.L., Lai, K.P., Chen, C.A., Yang, C.Y., Chen, P.S., Chang, C.C., A novel peptide specifically binding to interleukin-6 receptor (gp80) inhibits angiogenesis and tumor growth (2005) Cancer Res, 65, pp. 4827-4835", "listPosition" : 87, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790506, "link" : "/api/reference/16790506", "label" : "88. Merrifield, R.B., Solid phase peptide synthesis (1963) J Am Chem Soc, 85, pp. 2149-2154", "listPosition" : 88, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790507, "link" : "/api/reference/16790507", "label" : "89. Merrifield, B., Concept and early development of solid-phase peptide synthesis (1997) Methods Enzymol, 289, pp. 3-13", "listPosition" : 89, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790508, "link" : "/api/reference/16790508", "label" : "90. Fields, G.B., Solid phase peptide synthesis (1997) Methods Enzymol, p. 289", "listPosition" : 90, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790509, "link" : "/api/reference/16790509", "label" : "91. Geysen, H.M., Meloen, R.H., Barteling, S.J., Use of peptide synthesis to probe viral antigens for epitopes to a resolution of a single amino acid (1984) Proc Natl Acad Sci USA, 81, pp. 3998-4002", "listPosition" : 91, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790510, "link" : "/api/reference/16790510", "label" : "92. Graven, A., St Hilaire, P.M., Sanderson, S.J., Mottram, J.C., Coombs, G.H., Meldal, M., Combinatorial library of peptide isosters based on Diels-Alder reactions: Identification of novel inhibitors against a recombinant cysteine protease from Leishmania mexicana (2001) J Comb Chem, 3, pp. 441-452", "listPosition" : 92, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790511, "link" : "/api/reference/16790511", "label" : "93. Fodor, S.P., Read, J.L., Pirrung, M.C., Stryer, L., Lu, A.T., Solas, D., Light-directed, spatially addressable parallel chemical synthesis (1991) Science, 251, pp. 767-773", "listPosition" : 93, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790512, "link" : "/api/reference/16790512", "label" : "94. Frank, R., Spot-synthesis: An easy technique for the positiionally addressable, parallel chemical synthesis on a membrane support (1992) Tetrahedron, 48, pp. 9217-9232", "listPosition" : 94, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790513, "link" : "/api/reference/16790513", "label" : "95. Pellois, J.P., Zhou, X., Srivannavit, O., Zhou, T., Gulari, E., Gao, X., Individually addressable parallel peptide synthesis on microchips (2002) Nat Biotechnol, 20, pp. 922-926", "listPosition" : 95, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790514, "link" : "/api/reference/16790514", "label" : "96. Frank, R., The SPOT-synthesis technique. Synthetic peptide arrays on membrane supports - principles and applications (2002) J Immunol Methods, 267, pp. 13-26", "listPosition" : 96, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790515, "link" : "/api/reference/16790515", "label" : "97. Weiser, A.A., Or-Guil, M., Tapia, V., Leichsenring, A., Schuchhardt, J., Frommel, C., SPOT synthesis: Reliability of army-based measurement of peptide binding affinity (2005) Anal Biochem, 342, pp. 300-311", "listPosition" : 97, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790516, "link" : "/api/reference/16790516", "label" : "98. TECAN application notes. November 2000; Doc. No 391: 556Weiler, J., Gausepohl, H., Hauser, N., Jensen, O.N., Hoheisel, J.D., Hybridisation based DNA screening on peptide nucleic acid (PNA) oligomer arrays (1997) Nucleic Acids Res, 25, pp. 2792-2799", "listPosition" : 98, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790517, "link" : "/api/reference/16790517", "label" : "99. Ast, T., Heine, N., Germeroth, L., Schneider-Mergener, J., Wenschuh, H., Efficient parallel synthesis of peptomers and peptoids on membranes (1999) Tetrahedron Lett, 40, pp. 4317-4318", "listPosition" : 99, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790518, "link" : "/api/reference/16790518", "label" : "100. Azzazy, H.M., Highsmith Jr., W.E., Phage display technology: Clinical applications and recent innovations (2002) Clin Biochem, 35, pp. 425-445", "listPosition" : 100, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790519, "link" : "/api/reference/16790519", "label" : "101. Samoylova, T.I., Morrison, N.E., Globa, L.P., Cox, N.R., Peptide phage display: Opportunities for development of personalized anti-cancer strategies. Anticancer Agents (2006) Med Chem, 6, pp. 9-17", "listPosition" : 101, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790520, "link" : "/api/reference/16790520", "label" : "102. Welsh, S.J., Bellamy, W.T., Briehl, M.M., Powis, G., The redox protein thioredoxin-1 (Trx-1) increases hypoxia-inducible factor 1 protein expression: Trx-1 overexpression results in increased vascular endothelial growth factor production and enhanced tumor angiogenesis (2002) Can Res, 62, pp. 5089-5095", "listPosition" : 102, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790521, "link" : "/api/reference/16790521", "label" : "103. Krusius, T., Ruoslahti, E., Primary structure of an extracellular matrix proteoglycan core protein deduced from cloned cDNA (1986) Proc Natl Acad Sci USA, 83, pp. 7683-7687", "listPosition" : 103, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790522, "link" : "/api/reference/16790522", "label" : "104. Tucker, R.P., The thrombospondin type 1 repeat superfamily (2004) Int J Biochem Cell Biol, 36, pp. 969-974", "listPosition" : 104, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790523, "link" : "/api/reference/16790523", "label" : "105. Koh, J.T., Kook, H., Kee, H.J., Seo, Y.W., Jeong, B.C., Lee, J.H., Extracellular fragment of brain-specific angiogenesis inhibitor 1 suppresses endothelial cell proliferation by blocking alphavbeta5 integrin (2004) Exp Cell Res, 294, pp. 172-184", "listPosition" : 105, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790524, "link" : "/api/reference/16790524", "label" : "106. Liu, Y.J., Xu, Y., Yu, Q., Full-length ADAMTS-1 and the ADAMTS-1 fragments display pro- and antimetastatic activity, respectively (2006) Oncogene, 25, pp. 2452-2467", "listPosition" : 106, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790525, "link" : "/api/reference/16790525", "label" : "107. Kini, R.M., Evans, H.J., A hypothetical structural role for proline residues in the flanking segments of protein interaction site (1995) Biochem Biophys Res Commun, 212, pp. 1115-1124", "listPosition" : 107, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790526, "link" : "/api/reference/16790526", "label" : "108. Kini, R.M., Evans, H.J., A common structural feature enclosing interaction sites: Prediction of protein-protein interaction sites and development of potent bioactive peptides (1994) Curr Topics Peptide Prot Res, 1, pp. 297-311", "listPosition" : 108, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790527, "link" : "/api/reference/16790527", "label" : "109. Kini, R.M., Proline brackets and identification of potential functional sites in proteins: Toxins to therapeutics (1998) Toxicon, 36, pp. 1659-1670", "listPosition" : 109, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790528, "link" : "/api/reference/16790528", "label" : "110. Kini, R.M., Evans, H.J., A novel approach to the design of potent bioactive peptides by incorporation of praline brackets: Antiplatelet effects of Arg-Gly-Asp peptides (1995) FEBS Lett, 375, pp. 15-17", "listPosition" : 110, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790529, "link" : "/api/reference/16790529", "label" : "111. Kini, R.M., Caldwell, R.A., Wu, Q.Y., Baumgarten, C.M., Feher, J.J., Evans, H.J., Flanking proline residues identify the L -type Ca2+ channel binding site of calciseptine and FS2 (1998) Biochemistry, 37, pp. 9058-9063", "listPosition" : 111, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790530, "link" : "/api/reference/16790530", "label" : "112. Tan, D.C., Kini, R.M., Jois, S.D., Lim, D.K., Xin, L., Ge, R., A small peptide derived from Flt-I (VEGFR-1) functions as an angiogenic inhibitor (2001) FEBS Lett, 494, pp. 150-156", "listPosition" : 112, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790531, "link" : "/api/reference/16790531", "label" : "113. Fawell, S., Seery, J., Daikh, Y., Moore, C., Chen, L.L., Pepinsky, B., Tat-mediated delivery of heterologous proteins into cells (1994) Proc Natl Acad Sci USA, 91, pp. 664-668", "listPosition" : 113, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790532, "link" : "/api/reference/16790532", "label" : "114. Buschle, M., Schmidt, W., Zauner, W., Mechtler, K., Trska, B., Kirlappos, H., Transloading of tumor antigen-derived peptides into antigen-presenting cells (1997) Proc Natl Acad Sci USA, 94, pp. 3256-3261", "listPosition" : 114, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790533, "link" : "/api/reference/16790533", "label" : "115. El-Andaloussi, S., Holm, T., Langel, U., Cell-penetrating peptides: Mechanisms and applications (2005) Curr Pharm Des, 11, pp. 3597-3611", "listPosition" : 115, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790534, "link" : "/api/reference/16790534", "label" : "116. Wender, P.A., Mitchell, D.J., Pattabiraman, K., Pelkey, E.T., Steinman, L., Rothbard, J.B., The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: Peptoid molecular transporters (2000) Proc Natl Acad Sci USA, 97, pp. 13003-13008", "listPosition" : 116, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790535, "link" : "/api/reference/16790535", "label" : "117. Vives E. Present and future of cell-penetrating peptide mediated delivery systems: Is the Trojan horse too wild to go only to Troy?J Control Release 2005; 109: 77-85Corti, A., Ponzoni, M., Tumor vascular targeting with tumor necrosis factor alpha and chemotherapeutic drugs (2004) Ann N Y Acad Sci, 1028, pp. 104-112", "listPosition" : 117, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790536, "link" : "/api/reference/16790536", "label" : "118. Curnis, F., Gasparri, A., Sacchi, A., Longhi, R., Corti, A., Coupling tumor necrosis factor-alpha with alphaV integrin ligands improves its antineoplastic activity (2004) Cancer Res, 64, pp. 565-571", "listPosition" : 118, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790537, "link" : "/api/reference/16790537", "label" : "119. Nasulewicz, A., Mazur, A., Opolski, A., Role of copper in tumour angiogenesis - clinical implications (2004) J Trace Elem Med Biol, 18, pp. 1-8", "listPosition" : 119, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790538, "link" : "/api/reference/16790538", "label" : "120. Quagraine, E.K., Kraatz, H.B., Reid, R.S., Peptides mimicking the N-terminal Cu(II)-binding site of bovine serum albumin: Synthesis, characterization and coordination with Cu(II) ions (2001) J Inorg Biochem, 85, pp. 23-32", "listPosition" : 120, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790539, "link" : "/api/reference/16790539", "label" : "121. Blaskovich, M.A., Lin, Q., Delarue, F.L., Sun, J., Park, H.S., Coppola, D., Design of GFB-111, a platelet-derived growth factor binding molecule with antiangiogenic and anticancer activity against human tumors in mice (2000) Nat Biotechnol, 18, pp. 1065-1070", "listPosition" : 121, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790540, "link" : "/api/reference/16790540", "label" : "122. Senel, S., Kremer, M., Nagy, K., Squier, C., Delivery of bioactive peptides and proteins across oral (buccal) mucosa (2001) Curr Pharm Biotechnol, 2, pp. 175-186", "listPosition" : 122, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790541, "link" : "/api/reference/16790541", "label" : "123. Noy, A., Scadden, D.T., Lee, J., Dezube, B.J., Aboulafia, D., Tulpule, A., Angiogenesis inhibitor IM862 is ineffective against AIDS-Kaposi's sarcoma in a phase III trial, but demonstrates sustained, potent effect of highly active antiretroviral therapy: From the AIDS Malignancy Consortium and IM862 Study Team (2005) J Clin Oncol, 23, pp. 990-998", "listPosition" : 123, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790542, "link" : "/api/reference/16790542", "label" : "124. Deplanque, G., Madhusudan, S., Jones, P.H., Wellmann, S., Christodoulos, K., Talbot, D.C., Phase II trial of the antiangiogenic agent IM862 in metastatic renal cell carcinoma (2004) Br J Cancer, 91, pp. 1645-1650", "listPosition" : 124, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790543, "link" : "/api/reference/16790543", "label" : "125. Tulpule, A., Scadden, D.T., Espina, B.M., Cabriales, S., Howard, W., Shea, K., Results of a randomized study of IM862 nasal solution in the treatment of AIDS-related Kaposi's sarcoma (2000) J Clin Oncol, 18, pp. 716-723", "listPosition" : 125, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790544, "link" : "/api/reference/16790544", "label" : "126. Hoekstra, R., de Vos, F.Y., Eskens, F.A., Gietema, J.A., van der Gaast, A., Groen, H.J., Phase I safety, pharmacokinetic, and pharmacodynamic study of the thrombospondin-1 -mimetic angiogenesis inhibitor ABT-510 in patients with advanced cancer (2005) J Clin Oncol, 23, pp. 5188-5197", "listPosition" : 126, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790545, "link" : "/api/reference/16790545", "label" : "127. Hawkins, R.E., Daigneault, L., Cowan, R., Griffiths, R., Panchal, C., Armstrong, A., Safety and tolerability of PCK3145, a synthetic peptide derived from prostate secretory protein 94 (PSP94) in metastatic hormone-refractory prostate cancer (2005) Clin Prostate Cancer, 4, pp. 91-99", "listPosition" : 127, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790546, "link" : "/api/reference/16790546", "label" : "128. Annabi, B., Bouzeghrane, M., Currie, J.C., Hawkins, R., Dulude, H., Daigneault, L., A PSP94-derived peptide PCK3145 inhibits MMP-9 secretion and triggers CD44 cell surface shedding: Implication in tumor metastasis (2005) Clin Exp Metastasis, 22 (5), pp. 429-439", "listPosition" : 128, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790547, "link" : "/api/reference/16790547", "label" : "129. Lamy, S., Ruiz, M.T., Wisniewski, J., Garde, S., Rabbani, S.A., Panchal, C., A prostate secretory protein94-derived synthetic peptide PCK3145 inhibits VEGF signaling in endothelial cells: Implication in tumor angiogenesis (2006) Int J Cancer, 118, pp. 2350-2358", "listPosition" : 129, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790548, "link" : "/api/reference/16790548", "label" : "130. Konstantinopoulos, P.A., Vandoros, G.P., Papavassiliou, A.G., FK228 (depsipeptide): A HDAC inhibitor with pleiotropic antitumor activities (2006) Cancer Chemother Pharmacol, 58, pp. 711-715", "listPosition" : 130, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790549, "link" : "/api/reference/16790549", "label" : "131. Faivre, S., Chieze, S., Delbaldo, C., Ady-Vago, N., Guzman, C., Lopez-Lazaro, L., Phase I and pharmacokinetic study of aplidine, a new marine cyclodepsipeptide in patients with advanced malignancies (2005) J Clin Oncol, 23, pp. 7871-7880", "listPosition" : 131, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790550, "link" : "/api/reference/16790550", "label" : "132. Van Laarhoven, H.W., Gambarota, G., Heerschap, A., Lok, J., Verhagen, I., Corti, A., Effects of the tumor vasculature targeting agent NGR-TNF on the tumor microenvironment in murine lymphomas (2006) Invest New Drugs, 24, pp. 27-36", "listPosition" : 132, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790551, "link" : "/api/reference/16790551", "label" : "133. Adessi, C., Soto, C., Converting a peptide into a drug: Strategies to improve stability and bioavailability (2002) Curr Med Chem, 9, pp. 963-978", "listPosition" : 133, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790552, "link" : "/api/reference/16790552", "label" : "134. Veronese, F.M., Pasut, G., PEGylation, successful approach to drug delivery (2005) Drug Discov Today, 10, pp. 1451-1458", "listPosition" : 134, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790553, "link" : "/api/reference/16790553", "label" : "135. Mitra A, Mulholland J, Nan A, McNeill E, Ghandehari H, Line BR. Targeting tumor angiogenic vasculature using polymer-RGD conjugates. J Control Release 2005; 102: 191-201Eskens, F.A., Dumez, H., Hoekstra, R., Perschl, A., Brindley, C., Bottcher, S., Phase I and pharmacokinetic study of continuous twice weekly intravenous administration of Cilengitide (EMD 121974), a novel inhibitor of the integrins alphavbeta3 and alphavbeta5 in patients with advanced solid tumours (2003) Eur J Cancer, 39, pp. 917-926", "listPosition" : 135, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790554, "link" : "/api/reference/16790554", "label" : "136. Cilengitide Merck, S.J.W., (2003) Curr Opin Investig Drugs, 4, pp. 741-745", "listPosition" : 136, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790555, "link" : "/api/reference/16790555", "label" : "137. Luttun, A., Autiero, M., Tjwa, M., Carmeliet, C., (2004) Genetic dissection of tumor angiogenesis: Are P1GF and VEGFR-1 novel anti-cancer targets?Biochim Biophy, 1654, pp. 79-94. , Acta", "listPosition" : 137, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790556, "link" : "/api/reference/16790556", "label" : "138. Dogne, J.M., Hanson, J., de Leval, X., Pratico, D., Pace-Asciak, C.R., Drion, P., From the design to the clinical application of thromboxane modulators (2006) Curr Pharm Des, 12 (8), pp. 903-923", "listPosition" : 138, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790557, "link" : "/api/reference/16790557", "label" : "139. Eichler, W., Yafai, Y., Wiedemann, P., Fengler, D., Antineovascular agents in the treatment of eye diseases (2006) Curr Pharm Des, 12 (21), pp. 2645-2660", "listPosition" : 139, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 16790558, "link" : "/api/reference/16790558", "label" : "140. Yasui, K., Kobayashi, N., Yamazaki, T., Agematsu, K., Thalidomide as an immunotherapeutic agent: The effects on neutrophil-mediated inflammation (2005) Curr Pharm Des, 11 (3), pp. 395-401", "listPosition" : 140, "published" : false, "snippet" : true } ], "hasCitationDuplums" : false, "userChangeableUntil" : "2013-02-10T22:06:05.000+0000", "publishDate" : "2013-02-10T22:06:01.000+0000", "directInstitutesForSort" : "", "ownerAuthorCount" : 3, "ownerInstituteCount" : 22, "directInstituteCount" : 0, "authorCount" : 2, "contributorCount" : 0, "hasQualityFactor" : true, "link" : "/api/publication/22942750", "label" : "Sulochana KN et al. Developing antiangiogenic peptide drugs for angiogenesis-related diseases. (2007) CURRENT PHARMACEUTICAL DESIGN 1381-6128 1873-4286 13 20 2074-2086", "template" : "